Calliditas Therapeutics A...

NASDAQ: CALT · Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM

Calliditas Therapeutics AB (publ) Ratios and Metrics

Financials in SEK. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-14.92 -11.38 -11.16
PEG Ratio
-1.28 0.51 -3.75
PS Ratio
5.76 5.84 24.80
PB Ratio
20.78 6.12 5.64
P/FCF Ratio
-15.55 -14.94 -11.75
P/OCF Ratio
-16 -15.06 -12.32
OCF/S Ratio
-0.36 -0.39 -2.01
Debt / Equity Ratio
2.92 0.95 0.21
Quick Ratio
3.08 4.33 7.47
Current Ratio
3.13 4.34 7.48
Asset Turnover
0.64 0.41 0.16
Interest Coverage
-5.25 -33.69 -73.78
Return on Equity
-1.39 -0.54 -0.51
Return on Assets
-0.25 -0.21 -0.35
Return on Invested Capital
-0.26 -0.26 -0.39
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.94 0.98 1.00
Net Profit Margin
-0.39 -0.51 -2.22
Pretax Profit Margin
-0.38 -0.51 -2.24
Operating Profit Margin
-0.32 -0.53 -2.29
FCF Margin
n/a n/a n/a
EBITDA Margin
-0.3 -0.48 -2.11